196 related articles for article (PubMed ID: 3105451)
1. In vitro activity of CGP 31608, a new penem.
Wise R; Andrews JM; Piddock LJ
Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agents.
Wise R; Cross C; Andrews JM
Antimicrob Agents Chemother; 1984 Dec; 26(6):876-80. PubMed ID: 6524904
[TBL] [Abstract][Full Text] [Related]
3. Review of the in vitro spectrum of activity of imipenem.
Jones RN
Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of CGP 31608, a new penem antibiotic.
Eliopoulos GM; Wennersten C; Reiszner E; Moellering RC
Antimicrob Agents Chemother; 1987 Aug; 31(8):1188-93. PubMed ID: 3498437
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
Yoshida T; Tateda E; Hiramatsu K; Yokota T
Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
Neu HC; Chin NX; Neu NM
Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
[TBL] [Abstract][Full Text] [Related]
7. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
Schrinner E; Limbert M; Seeger K; Seibert G; Novick WJ
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214
[TBL] [Abstract][Full Text] [Related]
8. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
Bauernfeind A
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
Gootz T; Retsema J; Girard A; Hamanaka E; Anderson M; Sokolowski S
Antimicrob Agents Chemother; 1989 Aug; 33(8):1160-6. PubMed ID: 2679370
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the novel penem CGP 31 608 and its enantiomer with type Id beta-lactamase and penicillin-binding proteins.
Mett H; Schacher B; Schneider P; Zak O
Eur J Clin Microbiol; 1987 Dec; 6(6):674-8. PubMed ID: 3126060
[TBL] [Abstract][Full Text] [Related]
11. Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics.
Wise R; Andrews JM; Danks G
Antimicrob Agents Chemother; 1983 Dec; 24(6):909-14. PubMed ID: 6607032
[TBL] [Abstract][Full Text] [Related]
12. The antimicrobial activity of cefpirome, a new cephalosporin.
Wise R; Andrews JM; Cross C; Piddock LJ
J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
[TBL] [Abstract][Full Text] [Related]
13. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Hikida M; Itahashi K; Igarashi A; Shiba T; Kitamura M
Antimicrob Agents Chemother; 1999 Aug; 43(8):2010-6. PubMed ID: 10428928
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Fukuoka T; Ohya S; Utsui Y; Domon H; Takenouchi T; Koga T; Masuda N; Kawada H; Kakuta M; Kubota M; Ishii C; Ishii C; Sakagawa E; Harasaki T; Hirasawa A; Abe T; Yasuda H; Iwata M; Kuwahara S
Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
Arisawa M; Sekine Y; Shimizu S; Takano H; Angehrn P; Then RL
Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
Nagano R; Shibata K; Adachi Y; Imamura H; Hashizume T; Morishima H
Antimicrob Agents Chemother; 2000 Mar; 44(3):489-95. PubMed ID: 10681308
[TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
Watanabe Y; Minami S; Hayashi T; Araki H; Kitayama R; Ochiai H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021
[TBL] [Abstract][Full Text] [Related]
20. The antimicrobial activity of cephalexin against old and new pathogens.
Jones RN; Preston DA
Postgrad Med J; 1983; 59 Suppl 5():9-15. PubMed ID: 6364091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
